One Patient's Journey: A Rapid-Acting Antidepressant that Modulates Glutamate, Sigma-1, and Monoaminergic Pathways

Overview

This branded symposium will highlight the current unmet needs in MDD and present a treatment option with rapid symptom improvement for adult patients with MDD